Biotech firm Galapagos-owned drug discovery company Argenta has signed a collaboration agreement with Denmark-based biotech Pcovery for the development of anti-fungal agents. Pcovery, founded in 2009, was spun out of Aarhus and Copenhagen universities’ collaboration the Centre for Membrane Pumps in Cells and Disease, otherwise known as the PUMPkin Centre. The biotech focuses on the…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
